167 related articles for article (PubMed ID: 15765027)
1. Immunotherapy and gene therapy of thyroid cancer.
Schott M; Scherbaum WA
Minerva Endocrinol; 2004 Dec; 29(4):175-87. PubMed ID: 15765027
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapeutics in development for prostate cancer.
Harzstark AL; Small EJ
Oncologist; 2009 Apr; 14(4):391-8. PubMed ID: 19342474
[TBL] [Abstract][Full Text] [Related]
3. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
Xia D; Moyana T; Xiang J
Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
[TBL] [Abstract][Full Text] [Related]
4. Development of immunotherapy for the treatment of malignancies refractory to conventional therapies.
Kim S; Haas GP; Hillman GG
Cytokines Mol Ther; 1996 Mar; 2(1):13-9. PubMed ID: 9384685
[TBL] [Abstract][Full Text] [Related]
5. Novel immunotherapeutic approaches to glioma.
Yamanaka R
Curr Opin Mol Ther; 2006 Feb; 8(1):46-51. PubMed ID: 16506525
[TBL] [Abstract][Full Text] [Related]
6. Technology insight: gene therapy and its potential role in the treatment of medullary thyroid carcinoma.
Messina M; Robinson BG
Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):290-301. PubMed ID: 17315037
[TBL] [Abstract][Full Text] [Related]
7. [State of the art about new therapeutic vaccines in prostate cancer: dendritic cells, engineered tumor cells and recombinant virus].
Eymard JC; Gervais A; Jarcau R; Bernard J
Bull Cancer; 2007 Jul; 94(7 Suppl):F69-76. PubMed ID: 17845996
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy in head and neck cancer: current practice and future possibilities.
Agada FO; Alhamarneh O; Stafford ND; Greenman J
J Laryngol Otol; 2009 Jan; 123(1):19-28. PubMed ID: 18761763
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy for colorectal cancer.
Midgley RS; Kerr DJ
Expert Rev Anticancer Ther; 2003 Feb; 3(1):63-78. PubMed ID: 12597351
[TBL] [Abstract][Full Text] [Related]
10. Melanoma and immunotherapy.
Eggermont AM; Schadendorf D
Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell based immunotherapy--a promising therapeutic approach for endocrine malignancies.
Sbiera S; Wortmann S; Fassnacht M
Horm Metab Res; 2008 Feb; 40(2):89-98. PubMed ID: 18283626
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma.
Papewalis C; Wuttke M; Jacobs B; Domberg J; Willenberg H; Baehring T; Cupisti K; Raffel A; Chao L; Fenk R; Seissler J; Scherbaum WA; Schott M
Horm Metab Res; 2008 Feb; 40(2):108-16. PubMed ID: 18283628
[TBL] [Abstract][Full Text] [Related]
13. Cancer immunotherapy.
Schuster M; Nechansky A; Kircheis R
Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for treating metastatic colorectal cancer.
Boghossian S; Robinson S; Von Delwig A; Manas D; White S
Surg Oncol; 2012 Jun; 21(2):67-77. PubMed ID: 21292476
[TBL] [Abstract][Full Text] [Related]
15. Medullary thyroid carcinoma: autologous tumor cell lines for dendritic cell vaccination.
Pfragner R; Skofitsch G; Höger H; Jech M; Rinner B; Siegl V; Niederle B; Gnant M; Friedl J; Stift A
Anticancer Res; 2005; 25(6B):4225-30. PubMed ID: 16309220
[TBL] [Abstract][Full Text] [Related]
16. Dendritic-cell tumor vaccines.
Rolinski J; Hus I
Transplant Proc; 2010 Oct; 42(8):3306-8. PubMed ID: 20970677
[TBL] [Abstract][Full Text] [Related]
17. Immunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers.
Schott M
Endocr Relat Cancer; 2006 Sep; 13(3):779-95. PubMed ID: 16954430
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in immunotherapy for human glioma.
Carpentier AF; Meng Y
Curr Opin Oncol; 2006 Nov; 18(6):631-6. PubMed ID: 16988586
[TBL] [Abstract][Full Text] [Related]
19. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
20. The immunotherapy of prostate and bladder cancer.
Totterman TH; Loskog A; Essand M
BJU Int; 2005 Oct; 96(5):728-35. PubMed ID: 16144528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
